RYDER. New Act Creates the Patient Access to Treatment Act. Provides that managed care entities may not deny or limit reimbursement to a member for dermatological services on the grounds that the member was not referred to the provider by a person acting on behalf of the managed care entity. Prohibits unreasonable cost-sharing arrangements. Requires terms and conditions of coverage to be disclosed in a readable and understandable format consistent with standards developed for supplemental insurance coverage under the federal Social Security Act. Effective immediately. 99-02-22 H FIRST READING 99-02-22 H REFERRED TO HOUSE RULES COMMITTEE RULES 99-02-24 H ASSIGNED TO COMMITTEE HEALTH CARE 99-03-05 H RE-REFERRED TO RULES COMM/RULE 19(A) RULES HRUL 01-01-09 H SESSION SINE DIE END OF INQUIRY Full Text Bill Summary